Filing Details
- Accession Number:
- 0001225208-14-011383
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-30 16:06:23
- Reporting Period:
- 2014-04-29
- Filing Date:
- 2014-04-30
- Accepted Time:
- 2014-04-30 16:06:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1385187 | Covidien Plc | COV | Surgical & Medical Instruments & Apparatus (3841) | 980624794 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1572883 | Douglas Brian King | C/O Covidien 15 Hampshire Street Mansfield MA 02048 | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2014-04-29 | 8,550 | $52.53 | 45,723 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2014-04-29 | 7,019 | $43.44 | 52,742 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2014-04-29 | 15,569 | $70.11 | 37,173 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2014-04-29 | 7,019 | $0.00 | 7,019 | $43.44 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2014-04-29 | 8,550 | $0.00 | 8,550 | $52.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-11-30 | No | 4 | M | Direct | |
| 25,650 | 2022-12-02 | No | 4 | M | Direct |
Footnotes
- Includes 3 shares acquired in connection with the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4.
- The price reported is the weighted average price. Shares were sold in multiple transactions at prices ranging from $70.10 to $70.121. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each price.
- Adjusted in connection with the spin-off of Covidien's pharmaceuticals business.
- Options became exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.
- Options become exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.
Billionaire Hedge Funds
